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Introduction :
Periodontitis is a term that describes a group of inflamma-
tory diseases affecting the periodontium. In cases of peri-
odontitis, alveolar bone loss is very common and recent pa-
pers have suggested that melatonin (chemical name : N−
acetyl−5−methoxy tryptamine) decreases aggressive inflam-
mation and alveolar bone loss in periodontitis. Melatonin is
a pineal gland indoleamine hormone with anti−inflammatory
and immunomodulatory effects (Kara et al., 2013 ; Arabaci
et al., 2015). Melatonin possesses antimicrobial properties
against a variety of bacteria and viruses ( Tekbas et al. ,
2008 ; Boga et al., 2012) and its lipophilic nature allows
the easy and rapid contact with cells and cellular compo-
nents (Menendez−Pelaez et al., 1993). Melatonin is present
in some foods including cherries, bananas, grapes, rice, ce-
real, herbs, plums, olive oil, wine, beer, orange, and pineap-
ple (Hattori et al., 1995 ; Catherine, 2011). It is medically
used in sleep disorders, jet lag, headaches, cancer, gall-
stones, protection from radiation, tinnitus, and psychiatric
disorders (Srinivasan et al., 2009). It causes very few side
effects, including dizziness and drowsiness (Buscemi et al.,
2005).
Antioxidant effects :
Melatonin is a wide−spectrum antioxidant and a powerful
scavenger of free−radical oxygen and nitrogen species (Ar-
nao and Hernandez−Ruiz , 2006 ; Tan et al., 1993). Mela-
tonin is an antioxidant that easily crosses cell membranes
and the blood–brain barrier (Poeggeler et al., 1994). Mela-
tonin was reported to be twice as active as vitamin E, which
was thought to be the most effective lipophilic antioxidant
(Lowes et al., 2013). An important characteristic of mela-
tonin that distinguishes it from other classic radical scaven-
gers is that its metabolites are also scavengers ; this is
termed “the cascade reaction” (Tan et al., 2007). Another
study indicated that melatonin also protects against mito-
chondrial oxidative stress (Carrillo−Vico et al., 205). In ad-
dition to its scavenger effects, melatonin indirectly stimu-
lates various antioxidant enzymes (Kara et al., 2013 ; Ara-
baci et al., 2015 ; ). Furthermore, melatonin is superior to
other antioxidants because it does not become pro−oxidative
when it loses an electron during interactions with free radi-
cals (Czesnikiewicz− Guzik et al., 2007).
Antidiabetic effects :
Many studies have also highlighted the potent antidiabetic
properties of melatonin (Golbidi et al., 2011 ; Zephy and
Ahmad, 2015 ; Muhlbauer et al. , 2007 ; Picinato et al. ,
2002 ) . Melatonin administration significantly reduced
plasma glucose levels in rats with diabetes mellitus (DM),
providing evidence that melatonin is a potent antidiabetic
(Limson et al., 1998 ; Dubocovich et al., 2010). It directly
affects insulin release by interacting with MT1 and MT2 re-
ceptors located on the surface of pancreatic beta cells (Muhl-
bauer et al., 2007). Melatonin inhibits adenylate cyclase−cy-
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Abstract
Alveolar bone loss is a very common phenomenon in
periodontal disease. Previous studies have suggested
that melatonin decreases aggressive inflammation and
alveolar bone loss in periodontitis. This article will re-
view the advanced effects of melatonin that might be
clinically beneficial for the treatment of diabetic or
non–diabetic periodontitis.
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clic adenosine monophosphate ( MT 1 and MT 2 ) and
guanylate cyclase−cyclic guanosine monophosphate systems
(MT2) via a Gi−protein signaling cascade to reduce the re-
lease of insulin (Limson et al., 1998 ; ). In addition, mela-
tonin synthesis was decreased when insulin release was in-
creased (Kemp et al. , 2002) and insulin release was de-
creased after melatonin administration (Picinato et al., 2002).
This close relationship between insulin and melatonin levels
indicates that melatonin supplementation might be beneficial
for controlling insulin levels and preventing diabetic compli-
cations (Kose et al., 2016).
Immunomodulatory effects :
Melatonin interacts with the immune system (Arusanian
and Beier, 2002). However, the details of these interactions
are unclear. The anti − inflammatory effects of melatonin
seem to be the most relevant and most documented in the
literature to date. However, there have been few trials de-
signed to judge the effectiveness of melatonin in disease
treatment. Most existing data are based on small, incomplete
clinical trials. Another study suggested melatonin might be
useful against infectious diseases (Limson et al., 1998) in-
cluding viral disease such as HIV, bacterial infections, and
cancer.
Effects on Periodontitis and Alveolar Bone Loss
A recent study evaluated the potential effects of melatonin
administration on myeloperoxidase (MPO) activity and al-
veolar bone destruction. MPO activities, osteoclasts, the
RANKL/osteoprotegerin (OPG) ratio and neutrophil densi-
ties were increased in periodontitis, which might be respon-
sible for alveolar bone loss (Kose et al., 2016). Melatonin
administration significantly reduced gingival tissue MPO
levels and stimulated the proliferation of osteoblasts to pro-
mote bone formation (Roth et al.,1999). Gingival tissue neu-
trophil density, RANKL−positive osteoclast density, and the
cemento−enamel junction/alveolar bone rest distance were
significantly higher in cases of periodontitis with and with-
out DM, but were significantly reduced following melatonin
administration. Although melatonin is a popular antioxidant
and antidiabetic agent, a limited number of studies have in-
vestigated the influence of melatonin on periodontitis (Kose
et al. , 2016 ) . Recent studies showed that melatonin de-
creased inflammation and alveolar bone loss in rats with pe-
riodontitis through its immunomodulatory and antioxidant
effects (Kara et al., 2013 ; Arabaci et al., 2015). Following
the treatment of mice with melatonin, the mineral apposition
rate and osteoid volume were increased, indicating that
melatonin predominantly increases bone mass, and sup-
presses osteoclast number and bone resorption ; however, it
did not increase the histomorphometric bone formation pa-
rameters (Koyama et al., 2002).
Topical use of Melatonin :
Cudanto et al. evaluated the effects of topical melatonin
(1% orabase cream formula) administered to the surface of
attached gingiva for 20 days in cases of periodontitis with
DM or healthy individuals (Cutando et al., 2014). The topi-
cal melatonin administration significantly decreased clinical
periodontal parameters (gingival index and probing depth),
alkaline and acid phosphatase enzyme levels, and RANKL
levels while increasing OPG levels (Cutando et al., 2013).
Systemic administration of Melatonin :
Kose et al. evaluated the effects of systemic melatonin
treatment on hyperglycemia−induced oxidative stress and al-
veolar bone loss (Kose et al., 2016). The study showed that
melatonin administration decreased neutrophil density and
MPO activity in cases of periodontitis with and without DM.
These effects might be associated with the ability of mela-
tonin to decrease neutrophil counts and phagocytic activity
in the periodontal field during the inflammatory activity of
periodontitis, which might prevent alveolar bone loss (Kose
et al., 2016). Furthermore, melatonin regulates the number
and activities of osteoblasts and osteoclasts ( Kose et al. ,
2016). A significant reduction in alveolar bone loss after
melatonin administration might be related to its regulation of
oxidative and inflammatory balances via its antioxidant, im-
munomodulatory, and antidiabetic effects ( Kose et al. ,
2016).
Summary :
Melatonin might be clinically beneficial for the treatment
of diabetic or non−diabetic periodontitis. However, addi-
tional studies are required to explain the effectiveness of
melatonin for the treatment of periodontitis and bone loss.
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